Starpharma Quote - SPL

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.115

Bid

0.11

Offer

0.115

Volume

138,359

0.11 Day's Range 0.115

0.086 52 Week Range 0.195

Market Cap

47.018M

Previous Close

0.115

Open

0.115

Last Trade

624

0.115

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

605,827

Shares Outstanding

408,852,447

Dividend Yield

PE Ratio

-5.50

Earnings Per Share (EPS)

-0.02

Revenue

13.82M

Net Profit

-8.17M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.starpharma.com

Headquarters

Melbourne, Victoria, Aus

Founded

2000

Starpharma Holdings Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker SPL. The last closing price for Starpharma was AUD0.12. Over the last year, Starpharma shares have traded in a share price range of AUD 0.086 to AUD 0.195.

Starpharma currently has 408,852,447 shares in issue. The market capitalisation of Starpharma is AUD47.02 million. Starpharma has a price to earnings ratio (PE ratio) of -5.50.

Starpharma to Webcast Live at Life Sciences Investor Forum June 24th

MELBOURNE, Australia, June 24, 2021 (GLOBE NEWSWIRE) -- Starpharma (ASX: SPL, OTCQX: SPHRY), based in Melbourne, Australia, today announced that Dr. Jackie Fairley, Chief Executive Officer, will...

Starpharma’s SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

New data generated at Scripps Research Institute in the US shows that Starpharma’s antiviral nasal spray active (SPL7013) is virucidal, inactivating more than 99.9% of SARS-CoV-2, the virus that...

Starpharma’s SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

New data generated at Scripps Research Institute in the US shows that Starpharma’s antiviral nasal spray active (SPL7013) is virucidal, inactivating more than 99.9% of SARS-CoV-2, the virus that...

Starpharma creates slow release soluble DEP remdesivir nanoparticle

DEP® remdesivir has been created to expand the potential application of remdesivir, by creating a long-acting version which could be administered subcutaneously rather than by intravenous...

Starpharma SPL7013 Nasal Spray for COVID-19 – Development Update

Product development activities for SPL7013, repurposed as an antiviral nasal spray, are now well advanced with formulations developed, a manufacturer selected and pilot manufacture undertaken...

Starpharma’s SPL7013 Shows Significant Activity Against SARS-CoV-2 (coronavirus)

Starpharma’s antiviral dendrimer, SPL7013, has been shown to have significant activity against SARS-CoV-21 (coronavirus), which causes COVID-19 SPL7013 is the active component in Starpharma’s...

Starpharma: Commencement of Phase 1 Trial for AZD0466 Utilising DEP® Delivery Technology

AstraZeneca has commenced its first-in-human/phase 1 clinical trial for AZD0466 in the US in a range of cancers AZD0466 utilises Starpharma’s proprietary DEP® delivery technology and is a highly...

Starpharma Signs Second Oncology Agreement With AstraZeneca

Starpharma has signed a Development and Option Agreement with AstraZeneca to progress the development of a Dendrimer Enhanced Product (DEP®) version of one of AstraZeneca’s major...

VivaGel® Condom Receives Final Regulatory Approval in Japan

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that the VivaGel® condom has received final regulatory approval and is now able to be marketed in Japan, following the completion of the...

Starpharma Licenses VivaGel® BV to Mundipharma for Europe

Starpharma licenses VivaGel® BV to Mundipharma for Europe, Russia, CIS1 and the balance of Latin America to be marketed as part of the popular BETADINE® Feminine Care portfolio Deal...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.005	4.54545454545	0.11	0.12	0.105	249234	0.11388832	DE
4	0.018	18.5567010309	0.097	0.125	0.096	511971	0.10599501	DE
12	0.018	18.5567010309	0.097	0.125	0.088	605827	0.09844296	DE
26	0.005	4.54545454545	0.11	0.125	0.086	613604	0.09624865	DE
52	-0.02	-14.8148148148	0.135	0.195	0.086	507085	0.11268585	DE
156	-1.105	-90.5737704918	1.22	1.375	0.086	524219	0.33207613	DE
260	-1.23	-91.4498141264	1.345	2.52	0.086	592005	0.86270969	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AL8Alderan Resources Limited	AUD 0.026 (766.67%)	385.55k
EFEEastern Resources Ltd	AUD 0.03 (650.00%)	125.43k
AL8OAAlderan Resources Limited	AUD 0.003 (200.00%)	310.51k
GEDOGolden Deeps Limited	AUD 0.002 (100.00%)	1.31M
IVXInvion Ltd	AUD 0.36 (100.00%)	908.13k
M2ROAMiramar Resources Limited	AUD 0.001 (-50.00%)	1.35M
MHCManhattan Corporation Limited	AUD 0.001 (-50.00%)	250.33k
EXLDBElixinol Wellness Limited	AUD 0.004 (-50.00%)	412.82k
NHEONoble Helium Ltd	AUD 0.002 (-33.33%)	485.39k
VPRVolt Group Ltd	AUD 0.001 (-33.33%)	32.51k
IXRIonic Rare Earths Limited	AUD 0.006 (-14.29%)	80.52M
IONIondrive Limited	AUD 0.02 (66.67%)	68.36M
OVTOvanti Ltd	AUD 0.021 (0.00%)	52M
TMGTrigg Minerals Ltd	AUD 0.04 (-11.11%)	45.8M
ZIPZip Co Limited	AUD 3.395 (-0.73%)	44.19M